Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study

Julita Szulimowska; Anna Zalewska; Katarzyna Taranta-Janusz; Daria Trocka; Małgorzata Żendzian-Piotrowska; Ryszard Tomasiuk; Mateusz Maciejczyk

doi:10.12659/MSM.942230

14 December 2023: Clinical Research

Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study

Julita Szulimowska ^1ABCDEF , Anna Zalewska ^1ACD , Katarzyna Taranta-Janusz ^2ABD , Daria Trocka ^3C , Małgorzata Żendzian-Piotrowska ^4C , Ryszard Tomasiuk ^5C , Mateusz Maciejczyk ^4ACDEFG*

DOI: 10.12659/MSM.942230

Med Sci Monit 2023; 29:e942230

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 3 Research plan and conclusions (generated using biorender.com). The concentration of IMA in non-stimulated whole saliva is negatively correlated with the estimated glomerular filtration rate (eGFR). IMA levels in the serum and urine of patients do not have diagnostic value for assessing the progression of chronic kidney disease (CKD).

Back to the Article

Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study

Your Privacy